A Clinical Study to Evaluate the Efficacy and Safety of Recombinant Botulinum Toxin Type a (YY001) for Injection in the Treatment of Upper Limb Spasticity in Adults (REHAB-1)
Latest Information Update: 24 Jan 2025
Price :
$35 *
At a glance
- Drugs YY-001 (Primary)
- Indications Muscle spasticity
- Focus Therapeutic Use
- Acronyms REHAB-1
- Sponsors Chongqing Claruvis Pharmaceutical
- 24 Jan 2025 New trial record